2m 2m 2m 2m 2m 2m 2m
GT BIOPHARMA (GTBP)
NASDAQ
$0.40+$0.008 (+2.14%)
Price as of Jul 14, 2026 4:56 AM EDT- $15.3MMarket Cap
- -81.88%1-Year Change
- BiotechnologyIndustry
GT BIOPHARMA (GTBP)
$0.40+$0.008 (+2.14%)
GTBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.39 | ||
Change | -$0.04 (-8.78%) | ||
Open | $0.41 | ||
High | $0.42 | ||
Low | $0.37 | ||
Previous Close | $0.42 | ||
Volume | 1,720,504 | ||
30-Day Average Volume | 1,334,574 | ||
1-Week Change | -20.85% | ||
1-Month Change | -13.27% | ||
1-Year Change | -81.88% | ||
3-Year Change | -95.40% | ||
5-Year Change | -99.91% | ||
Fundamentals | |||
Shares Outstanding | 36.1M | ||
Total Assets | $10.0M | ||
Market Cap | $15.3M | ||
Enterprise Value | $6.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.4M | ||
Free Cash Flow | -$2.5M | ||
EBIT | -$3.4M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $7.6M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/05/2024 | ||
Earnings & Revenue